Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F1AM5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,115
Award facts
- Contract value 100% obligated
- $23,114.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $23,114.88 on January 22, 2026, by the Defense Logistics Agency (DLA) for the supply of Enhertu 100 mg vials. This firm fixed-price, non-set-aside contract is scheduled for completion by February 12, 2026, with performance occurring at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is executed under a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Enhertu is a specialized oncology medication used in cancer treatment, reflecting AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill open competition requirements and efficiently deliver essential pharmaceutical and medical commodities across multiple therapeutic domains. This delivery order represents one of numerous task orders executed under the company's prime vendor agreement with the DLA, enabling support for military treatment facilities and other federal medical institutions globally.
Quick answers
Who was awarded contract SPE2DR26F1AM5?
SPE2DR26F1AM5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1AM5 worth?
The government has obligated $23,115 on SPE2DR26F1AM5.
Is contract SPE2DR26F1AM5 an order under another contract?
Yes. SPE2DR26F1AM5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AM5 competed?
The extent of competition for SPE2DR26F1AM5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award